162 related articles for article (PubMed ID: 22672303)
1. Drug binding assays do not reveal specific binding of lacosamide to collapsin response mediator protein 2 (CRMP-2).
Wolff C; Carrington B; Varrin-Doyer M; Vandendriessche A; Van der Perren C; Famelart M; Gillard M; Foerch P; Rogemond V; Honnorat J; Lawson A; Miller K
CNS Neurosci Ther; 2012 Jun; 18(6):493-500. PubMed ID: 22672303
[TBL] [Abstract][Full Text] [Related]
2. In silico docking and electrophysiological characterization of lacosamide binding sites on collapsin response mediator protein-2 identifies a pocket important in modulating sodium channel slow inactivation.
Wang Y; Brittain JM; Jarecki BW; Park KD; Wilson SM; Wang B; Hale R; Meroueh SO; Cummins TR; Khanna R
J Biol Chem; 2010 Aug; 285(33):25296-307. PubMed ID: 20538611
[TBL] [Abstract][Full Text] [Related]
3. Lacosamide: a review of preclinical properties.
Beyreuther BK; Freitag J; Heers C; Krebsfänger N; Scharfenecker U; Stöhr T
CNS Drug Rev; 2007; 13(1):21-42. PubMed ID: 17461888
[TBL] [Abstract][Full Text] [Related]
4. Inverted-U response of lacosamide on pilocarpine-induced status epilepticus and oxidative stress in C57BL/6 mice is independent of hippocampal collapsin response mediator protein-2.
Nirwan N; Siraj F; Vohora D
Epilepsy Res; 2018 Sep; 145():93-101. PubMed ID: 29935443
[TBL] [Abstract][Full Text] [Related]
5. Prevention of posttraumatic axon sprouting by blocking collapsin response mediator protein 2-mediated neurite outgrowth and tubulin polymerization.
Wilson SM; Xiong W; Wang Y; Ping X; Head JD; Brittain JM; Gagare PD; Ramachandran PV; Jin X; Khanna R
Neuroscience; 2012 May; 210():451-66. PubMed ID: 22433297
[TBL] [Abstract][Full Text] [Related]
6. (S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5.
Moutal A; François-Moutal L; Perez-Miller S; Cottier K; Chew LA; Yeon SK; Dai J; Park KD; Khanna M; Khanna R
Mol Neurobiol; 2016 Apr; 53(3):1959-1976. PubMed ID: 25846820
[TBL] [Abstract][Full Text] [Related]
7. (S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology.
Moutal A; Chew LA; Yang X; Wang Y; Yeon SK; Telemi E; Meroueh S; Park KD; Shrinivasan R; Gilbraith KB; Qu C; Xie JY; Patwardhan A; Vanderah TW; Khanna M; Porreca F; Khanna R
Pain; 2016 Jul; 157(7):1448-1463. PubMed ID: 26967696
[TBL] [Abstract][Full Text] [Related]
8. [Lacosamide. A new antiepileptic drug as adjunctive therapy in patients with partial-onset seizures].
Saussele T
Med Monatsschr Pharm; 2008 Oct; 31(10):374-7. PubMed ID: 18972867
[TBL] [Abstract][Full Text] [Related]
9. A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs.
Sake JK; Hebert D; Isojärvi J; Doty P; De Backer M; Davies K; Eggert-Formella A; Zackheim J
CNS Drugs; 2010 Dec; 24(12):1055-68. PubMed ID: 21090839
[TBL] [Abstract][Full Text] [Related]
10. Lacosamide, a newer antiepileptic.
Patyar S; Medhi B
Neurosciences (Riyadh); 2010 Jan; 15(1):3-6. PubMed ID: 20677583
[TBL] [Abstract][Full Text] [Related]
11. Specific binding of lacosamide to collapsin response mediator protein 2 (CRMP2) and direct impairment of its canonical function: implications for the therapeutic potential of lacosamide.
Wilson SM; Khanna R
Mol Neurobiol; 2015 Apr; 51(2):599-609. PubMed ID: 24944082
[TBL] [Abstract][Full Text] [Related]
12. Seeking a mechanism of action for the novel anticonvulsant lacosamide.
Errington AC; Coyne L; Stöhr T; Selve N; Lees G
Neuropharmacology; 2006 Jun; 50(8):1016-29. PubMed ID: 16620882
[TBL] [Abstract][Full Text] [Related]
13. Effect of lacosamide on structural damage and functional recovery after traumatic brain injury in rats.
Pitkänen A; Immonen R; Ndode-Ekane X; Gröhn O; Stöhr T; Nissinen J
Epilepsy Res; 2014 May; 108(4):653-65. PubMed ID: 24636248
[TBL] [Abstract][Full Text] [Related]
14. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
15. Adjunctive lacosamide in clinical practice: sodium blockade with a difference?
Stephen LJ; Kelly K; Parker P; Brodie MJ
Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421
[TBL] [Abstract][Full Text] [Related]
16. mTORC1-dependent translation of collapsin response mediator protein-2 drives neuroadaptations underlying excessive alcohol-drinking behaviors.
Liu F; Laguesse S; Legastelois R; Morisot N; Ben Hamida S; Ron D
Mol Psychiatry; 2017 Jan; 22(1):89-101. PubMed ID: 26952865
[TBL] [Abstract][Full Text] [Related]
17. Effect of lacosamide on ethanol induced conditioned place preference and withdrawal associated behavior in mice: Possible contribution of hippocampal CRMP-2.
Sharma N; Zameer S; Akhtar M; Vohora D
Pharmacol Rep; 2019 Oct; 71(5):804-810. PubMed ID: 31377562
[TBL] [Abstract][Full Text] [Related]
18. Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures.
Beydoun A; D'Souza J; Hebert D; Doty P
Expert Rev Neurother; 2009 Jan; 9(1):33-42. PubMed ID: 19102666
[TBL] [Abstract][Full Text] [Related]
19. Lacosamide modulates collapsin response mediator protein 2 and inhibits mossy fiber sprouting after kainic acid-induced status epilepticus.
Wang X; Yu Y; Ma R; Shao N; Meng H
Neuroreport; 2018 Nov; 29(16):1384-1390. PubMed ID: 30169428
[TBL] [Abstract][Full Text] [Related]
20. Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide.
Hebeisen S; Pires N; Loureiro AI; Bonifácio MJ; Palma N; Whyment A; Spanswick D; Soares-da-Silva P
Neuropharmacology; 2015 Feb; 89():122-35. PubMed ID: 25242737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]